SOD2 and metabolic dysfunction-associated steatotic liver disease: Nutritional and genetic NASH mouse models exhibited an increased expression in the levels of SOD2, paralleled by a significant impairment in its activity, which may reflect sensitivity to OxS in the later NAFLD stages [118].